Compare Cardinal Health Inc (CAH) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs Twist Bioscience Corp — how do they compare? Cardinal Health Inc trades at $240.57 (market cap $55.88B), while Twist Bioscience Corp trades at $124 (market cap $7.72B). The key difference: Cardinal Health Inc is far larger — about 7.2× Twist Bioscience Corp's market cap, and Cardinal Health Inc pays a 0.86% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| CAH | TWST | |
|---|---|---|
Market Cap | $55.88B | $7.72B |
Sector | Health | Health |
52-Week High | $240.26 | $124.88 |
52-Week Low | $146.04 | $24.16 |
Enterprise Value | $59.91B | $7.65B |
Dividend Yield | 0.86% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
